Foundation for Angelman Syndrome Therapeutics 在哪里?
Foundation for Angelman Syndrome Therapeutics 的总部位于 1151 stone mountain dr, downers grove, illinois, united states
Foundation for Angelman Syndrome Therapeutics 的电话号码是多少?
Foundation for Angelman Syndrome Therapeutics 的电话号码是 +1630-852-3278
Foundation for Angelman Syndrome Therapeutics 的官方网站是什么?
Foundation for Angelman Syndrome Therapeutics 的公司官方网站是 http://www.cureangelman.org
Foundation for Angelman Syndrome Therapeutics 是做什么的?
FAST is working to treat and cure Angelman syndrome. Find Angelman information and resources for families in our community.
Foundation for Angelman Syndrome Therapeutics 的业务有哪些?
Foundation for Angelman Syndrome Therapeutics 的年收入是多少?
Foundation for Angelman Syndrome Therapeutics 的收入是 3617000美元
Foundation for Angelman Syndrome Therapeutics 有多少员工?
Foundation for Angelman Syndrome Therapeutics 有 36 名员工
Foundation for Angelman Syndrome Therapeutics 属于哪个行业?
Foundation for Angelman Syndrome Therapeutics 从事以下行业: fund-raising
Foundation for Angelman Syndrome Therapeutics 使用什么技术?
Foundation for Angelman Syndrome Therapeutics 使用的一些流行技术包括: Apache,AppNexus,Bing Ads,Facebook Custom Audiences,Facebook Login (Connect),Facebook Widget,Gmail,Google Analytics,Google Apps,Google Font API,Google Maps,Google Plus,Google Tag Manager,Mailchimp Mandrill,Mobile Friendly,WordPress.org
如何联系 Foundation for Angelman Syndrome Therapeutics?
Foundation for Angelman Syndrome Therapeutics 联系信息:
电话号码:+1630-852-3278,
网站:http://www.cureangelman.org,
邮箱:lau***@***.org
Foundation for Angelman Syndrome Therapeutics 的社交媒体链接是什么?
Foundation for Angelman Syndrome Therapeutics 领英:http://www.linkedin.com/company/cureangelman,fackbook:https://www.facebook.com/cureangelman.org,twitte:https://twitter.com/cureangelman
Foundation for Angelman Syndrome Therapeutics 是一家上市公司吗?
不是
Foundation for Angelman Syndrome Therapeutics 的最后一轮融资是什么时候?
Foundation for Angelman Syndrome Therapeutics在2016-11-01T00:00:00.000+00:00结束了最后一轮融资,金额达5.8M$。
谁投资 Foundation for Angelman Syndrome Therapeutics?
Foundation for Angelman Syndrome Therapeutics 有 2 家投资者,包括 、California Institute for Regenerative Medicine。